Faculty – 14th PR & Communications Summit


Gaetan Akinrolabu
Associate Director, Social Media Publishing and Strategy, Corporate Affairs and Investor Relations, BRISTOL-MYERS SQUIBB


Jenifer Antonacci
Director, U.S. Public Affairs, INCYTE

view speaker profile

Jenifer Antonacci is an award-winning communications and public relations expert with accomplishments in corporate and product communications, internal and external communications, media relations, strategic alliance development, community relations, special events and corporate and executive visibility initiatives. At Incyte, Jenifer leads U.S. Public Affairs, including brand and disease education communications and patient advocacy.

Jenifer joined Incyte in March 2017 from Pfizer, where she led a team responsible for comprehensive communication to support brand and corporate initiatives in rare disease, inflammation and immunology, and vaccines, and has also led media strategy and engagement for the oncology and consumer (over-the-counter) businesses. Prior to joining Pfizer, Jenifer led PR strategy and tactical implementation at Cephalon Inc. and at Wyeth Pharmaceuticals. Jenifer is pursuing a Master’s in Public Administration and Policy online through American University and volunteers with The Leukemia & Lymphoma Society.


Michael Bachner
Director, Diabetes Business Unit Communications Legal and Corporate Affairs, NOVO NORDISK

view speaker profile

A seasoned communications strategist and passionate patient advocate, Michael offers 15 years of experience creating and executing solutions to complex communications challenges. Whether the challenge is a new product launch, label update, pivotal clinical data, safety concerns, litigation, pricing, manufacturing delays, or change communications Michael has delivered creative solutions that drive business results. He has a strong record of leading through change, giving a voice to the patient, building advocacy relationships, delivering a return on investment and protecting the reputation of the business through complex global organizations.


Dr. Terence Barnhart
Head of Process and Cultural Excellence, SANDOZ INC.

view speaker profile

Terry Barnhart is the head of process and cultural excellence at Sandoz. His current focus is on the rapid, deep and effective transformation of culture to make Sandoz the best, most rewarding, most effective place to work in the pharmaceutical industry. A critical aspect of this work is to answer a simple, critical question: How do we help people change their behaviors, their thoughts, and even their core beliefs for their mutual benefit and the benefit of the company? Answering this question requires a mix of advanced communications, a bit of psychology, a lot of listening, and the ability to bridge the experiences of multiple people at the same time.

Terry holds a Ph.D. in chemistry, has been a GE research scientist, a McKinsey consultant, and a Pfizer R&D strategist. While at Pfizer, he developed and deployed the field of continuous improvement for R&D to deliver more than half a billion dollars in top-line value in less than three years of effort. Terry has taught innovation and fast learning culture change at dozens of conferences around the world, at the US Marine Corps and Navy and for several companies. He has published a dozen scientific research papers, six patents and a book on creating a Lean R&D System in the pharmaceutical industry.


Joel W. Beetsch, Ph.D.
Vice President, Global Patient Advocacy, Corporate Affairs, CELGENE CORPORATION

view speaker profile

Joel Beetsch currently holds the position of Vice President of Global Patient Advocacy within the Celgene Corporate Affairs Department. In this position, Dr. Beetsch leads the global development and execution of a coordinated patient-focused Advocacy strategy working with multiple patient, provider, payer, and policy organizations to foster safe and effective solutions to healthcare challenges. These efforts drive the assurance that patient access to healthcare solutions and medical innovation and are valued and advanced.

During his 20-year tenure in the biopharmaceutical industry, Dr. Beetsch has held several Medical and Corporate Affairs positions. Joel has professional interests in patient-focused care coordination, health policy, and the use of health information technology. Joel is also one of the founding members of Project Data Sphere, a data sharing platform on which researchers can share, integrate, and analyze patient-level, deidentified, phase III cancer data. He has also served as the chairperson for the steering committee of the Reagan Udall Foundation Big Data for Patients (BD4P) initiative and is extensively engaged with the Clinical Trials Transformation Initiative (CTTI) efforts to connect patients and patient groups to the research and development process

Dr. Beetsch earned his Doctorate in Neurobiology/Biochemistry from the Boonshoft School of Medicine at Wright State University and further training at the Washington University School of Medicine. Joel lives in Mendham, New Jersey with his wife and two daughters.


Jim Blanchette
Director, U.S. Market Access, TAKEDA

view speaker profile

Jim Blanchette is the Director, U.S. Patient Value and Access at Takeda Oncology. In this role, he is responsible for helping patients gain access to the company’s blood and solid tumor therapy portfolio by working closely with payers and other external partners, focusing on federal reimbursement policy and value-based payment reform. A seasoned pharmaceutical executive with experience in both the lab and commercial settings, Jim brings a holistic perspective and understanding on the value and access environment. Jim has been with Takeda for the last six years and prior to joining, he spent seventeen years with Pfizer gaining experience across the R&D Commercial continuum. He has held R&D roles including scientist, early stage business development and alliance management. Jim’s commercial experience spans roles in market access, trade channel strategy, marketing and sales. Jim earned his MBA, Pharmacoepidemiology and Pharmacoeconomics through the Schools of Business and Pharmacy at the University of Rhode Island and an undergraduate degree in Chemistry at Providence College.


Jeff Boyle
Corporate Communications, SAGE THERAPEUTICS


Kristin Cahill
President, North America, GCI HEALTH

view speaker profile

Kristin works with a wide range of GCI Health’s pharmaceutical, biotechnology, medical device, health information technology and non-profit clients, with a particular focus on developing breakthrough strategies and creative programming. She also oversees new business development and North American operations at the agency.

Throughout her 14 years at GCI Health, Kristin has managed a number of high-profile, award-winning educational efforts around chronic diseases, including multiple sclerosis, chronic migraine, diabetes, fibromyalgia, rheumatoid arthritis, atrial fibrillation and multiple types of cancer.

Kristin takes a truly integrated approach to her client work and has served as the PR lead on a number of integrated WPP teams. She also has worked extensively with companies and brands facing access or administration challenges and scrutiny related to pricing, abuse potential, and marketing practices.

In 2005, Kristin received an honorable mention for PRWeek’s Young PR Professional of the Year award and in 2016, she was a finalist for PR News’ PR Professional of the Year. She has also contributed to a number of industry events and trade publications as an expert, including ExL Pharma, Bulldog Reporter, and MM&M.

Kristin graduated magna cum laude from Amherst College with a B.A. in psychology.


Larry Cardarelli
Vice President, MULTIVU PRODUCTION

view speaker profile

Larry started his career in business news, writing and producing for Lou Dobbs at CNN. He also freelanced for the BBC, Fox, and ABC News, as well as several independent production companies. In 2004, he was hired as a staff producer for MultiVu, the broadcast division of PR Newswire. Larry was instrumental in the development of the award-winning creative team at MultiVu; staffing writers, designers, illustrators, animators and creative producers. MultiVu Creative is a now a multimillion-dollar division of MultiVu Production.

Prior to his career in video production, Larry worked in several Manhattan restaurants including former New York Times 3-star March restaurant. He’s written for Food Arts Magazine and is a James Beard nominated television food producer.


Karen Carolonza
Managing Partner, GREEN ROOM COMMUNICATIONS

view speaker profile

Karen Carolonza is a proven public relations and communications professional with more than 20 years of global experience in the healthcare, chemical and TV news industries. Karen is one of the founding partners of Green Room Communications and built strategic communications teams and offices in Northern New Jersey, New York City and Cambridge, Massachusetts to meet the critical and evolving needs of her clients.

Before starting Green Room, Karen was the director of worldwide public relations at BD (Becton Dickinson & Company), a leading global health communications company and was responsible for the creation of the first-ever global public relations department. Karen supported the areas of internal and external communications, government relations, social investing and business marketing. She and her team developed public relations and advocacy programs in support of key businesses including, HIV/AIDS, TB, Diabetes, Influenza, Healthcare-Associated Infections, Ophthalmology, and other global health issues. During her time at BD, Karen liaised with UNAIDS to announce the Clinton Foundation’s move to cut prices on AIDS tests.

Prior to joining BD, Karen was responsible for public relations programs at the Pharmacia Corporation (now Pfizer) supporting the Hospital Products and Oncology businesses.

Karen also served as communications lead at DuPont-Merck as part of the launch team for the first, once-daily HIV medicine. She has additional expertise in corporate PR, including Exxon Chemical Company where she was hired away from TV news to help manage the Valdez crisis. Karen spent the first part of her career as an NBC affiliate television news reporter in the Midwest and East Coast, reporting on key healthcare and political issues.

Karen served as a volunteer on the CDC Foundation to advocate for Health Protection Goals. Karen is a member of the ExlPharma PR Steering Committee and chaired its annual national Summit for six years. She is also on the Boards of the Soft Bones Foundation, Mary’s Place by the Sea, the YMCA in northern New Jersey, and the Leading Women Entrepreneur in New Jersey.


Geoffrey Curtis
Senior Vice President, Corporate Affairs and Chief Communications Officer, HORIZON PHARMA

view speaker profile

Geoff Curtis serves as senior vice president, corporate affairs and chief communications officer at Horizon Pharma plc, a biopharmaceutical company, and is a member of the company’s executive committee. In this role, he oversees government affairs, patient advocacy, corporate social responsibility, corporate communications and consumer marketing and is responsible for the internal and external communications strategy. Geoff has more than two decades of global healthcare communications experience including media relations, issues management, internal communications, corporate and product communications and executive visibility.

Prior to joining Horizon Pharma, Geoff served senior vice president at Edelman Public Relations and as part of its National Health Media Team he led media strategy and execution for a large portfolio of pharmaceutical, biotech and medical device clients. He was responsible for developing and maintaining media relationships, as well as implementing media strategies to support regulatory and product milestones, data publication and global medical meetings.

Previously, Geoff was group director of the media practice at WCG, a W20 Group company, where he provided product and corporate communications counsel and handled ongoing media relations for a broad range of healthcare clients. Before WCG, he held a similar role at GCI Group.

Prior to joining GCI, Geoff served as a public affairs manager in the Pharmaceutical Products Division at Abbott (now AbbVie), where he led internal and external communications programs for the immunology, neuroscience and oncology franchises.

Geoff serves on the board of directors for the Illinois Science and Technology Coalition, CROSO (Child Restoration Outreach Support Organization and is a member of the Lake Forest College Alumni Board.


Monique Da Silva
Head, Corporate Communications, SPARK THERAPEUTICS

view speaker profile

Monique is a global communications leader with extensive experience in the biotechnology and healthcare industries. Currently, she leads Corporate Communications at Spark Therapeutics, a fully integrated commercial gene therapy company dedicated to challenging the inevitability of genetic disease. She is responsible all aspects of internal and external communications with key stakeholders to help advance Spark’s business objectives.
 
Previously, Monique led the U.S. Public Affairs group for Biogen, where she was responsible for advocacy relations, employee communications and external communications to support Biogen’s $6.5 Billion U.S. business during a period of intense growth.
 
Before Biogen, she worked in U.S. and global leadership positions at Ogilvy PR and MSLGroup, leading their healthcare practices.  She led Home Garden Marketing efforts for Johnny’s Selected Seeds, a high-quality seeds and gardening tools company, and was part of both the Public Affairs and the Marketing teams at Central Maine Power, based in Augusta, Maine.
 
Monique serves as president, Engagement Center of Excellence, for the Healthcare Businesswomen’s Association – New England, and on the board of directors of Mothers’ Milk Bank Northeast. She has a BA from Bowdoin College in Brunswick, Maine and completed the General Management Program at Harvard Business School.


Emily Y. Denney
Vice President, Global Communications and Corporate Philanthropy, WEST PHARMACEUTICAL SERVICES, INC.

view speaker profile

Emily Denney serves as the Vice President of Global Communications and Corporate Philanthropy. She leads the team responsible for designing, implementing and managing the global external and internal corporate communication strategy for West, including corporate and product external communication, media relations, crisis management, and internal communication. She also serves as the leader of West’s corporate giving initiatives.

Prior to joining West in 2014, Emily served as the Head of External Affairs at AstraZeneca Pharmaceuticals. In this role, Emily was responsible for leading the External Affairs Team, which worked with national, state and local-based third party patient and professional groups to form alliances with AstraZeneca. The team also managed all US philanthropic contributions to third party groups, totaling more than $15 million annually.

Emily worked at AstraZeneca for 17 years in a number of roles within US and Global Corporate Affairs.  During this time, she served as Leader of the Brand Corporate Affairs Team, providing strategic public relations and issues management counsel for the company’s portfolio of brands. In addition, she worked as a Director in US Corporate Communications, where she led the US Business corporate reputation efforts, as well as the External Media Relations team.  Emily also spent two years in AstraZeneca’s London office, serving as a Corporate Media Relations Press Officer.

In May of 2012, Emily was recognized by the Healthcare Businesswoman’s Association (HBA) as a 2012 “Rising Star.”  HBA Rising Stars are nominated by the association’s corporate partners and represent various career stages and disciplines, and have demonstrated noteworthy achievements.

Emily has a bachelor’s degree and master’s degree in Communication, both from the University of Delaware. She lives in West Chester, Pennsylvania, with her husband and three children, and volunteers at her children’s schools and sports teams. She is also an active alumni volunteer for the University of Delaware, and has worked to support the West Chester Food Cupboard.


Anthony Farina
Vice President, Corporate Affairs and Chief Communications Officer, CSL BEHRING

view speaker profile

Anthony is globally recognized as an innovative and results-oriented strategic communications leader with an established record of developing and leading creative, high-performance global teams that deliver against business objectives. He has held a range of progressive leadership roles during his 30-year communications career in both the private and public sectors, including as an Associated Press award-winning journalist and executive communications director for the governor of Delaware.

As the first Chief Communications Officer for one of the world’s largest — and oldest — biotech companies CSL Limited (ASX: CSL), Anthony leads strategic communications, brand and reputation management, and corporate affairs for the company in more than 60 countries with 21,000+ employees and nearly $10 billion in annual revenue.

Under Anthony’s leadership, CSL has evolved from “the largest company no one has ever heard of” to a global brand leader in rare diseases. He created CSL’s global Communications function, launched its first global brand positioning as well as employer brand, transformed its digital communications into leading-edge capabilities and developed a differentiated content strategy which is yielding tangible business results. During Anthony’s tenure, CSL’s CEO has emerged as a global thought leader, earning a number of recognitions including “CEO of the Year” by the highly respected Australian Financial Review. Forbes also named CSL among its Top 50 employers in the world in 2017 and 2018 for the first time.

Anthony was named among the world’s top 25 communications and marketing leaders as “Internationalist of the Year” in 2017 for championing innovative communications strategies and advocating responsible brand-building. He is widely recognized for his Public Relations excellence, including receiving the Best of Silver Anvil Award and 2 additional Silver Anvil Awards by the Public Relations Society of America (PRSA.)

Under Anthony’s global Public Affairs leadership for six years, DuPont progressively advanced in several leading global reputation indicators, including FORTUNE’s Top 50 “Most Admired Companies” list – named to the list for an unprecedented five consecutive years. As Anthony served as executive communications director for then-Delaware Gov. Thomas R. Carper, Carper’s approval ratings were between 77-82 percent — among the highest in the U.S. at the time.

Anthony is an active leader in the Arthur Page Society, the Communications Leadership Council and other industry associations. He has been featured in several leading communications industry publications — including PRSA’s “The Strategist,” profiled as a “Trendsetter” by The Internationalist and in the globally recognized “Holmes Report.”


Carrie Fernandez
Lead, US Communications, BRISTOL-MYERS SQUIBB

view speaker profile

Carrie has more than 20 years of professional experience, including pharmaceutical communications, corporate reputation initiatives, and health advocacy. Since 2016, Carrie has led U.S. Corporate Affairs for Bristol-Myers Squibb, with responsibility for internal/employee, product, access and pricing, and executive communications.

Carrie joined Bristol-Myers Squibb in March 2013 overseeing communications for the company’s HIV and hepatitis portfolios, during which she supported the launch of Daklinza in Japan and Europe. In early 2015 she transitioned to the World Wide communications lead for Opdivo/Yervoy where she played a key role in positioning the company as a leader in Immuno-Oncology.

Previously Carrie worked at Pfizer where she managed the U.S. and European approval and launch communications for Prevnar 13 adult, helping to position adult vaccination as a public health priority for adults 50+.

In addition to her corporate experience, Carrie has held positions at leading public agencies and third-party organizations where she managed scientific and product communications, disease-awareness campaigns, and issues management for a number of therapeutic areas, including vaccines, autoimmune diseases, and women’s health.

Carrie graduated from The George Washington University with a degree in International Business. She resides in New Jersey with her husband and daughter.


Gwen Fisher
Head, Global Portfolio Communications, SHIRE

view speaker profile

Gwen Fisher is a seasoned communications business leader with more than 25 years’ experience in corporate, employee, financial, merger and acquisition, advocacy, and marketing communications as well as media relations and issues management. She has a particular expertise in developing story narratives and messages as well as coaching senior corporate executives on how best to tell their stories, good or bad, to a variety of audiences, including employees and journalists. Gwen is also adept at developing and implementing effective, strategic communications plans in complex organizations undergoing major change and transformation.

Gwen joined Shire, the leading global biotechnology company focused in rare diseases, in January 2012. She currently heads Global Portfolio Communications. In this position, she leads the communications team responsible for developing and driving strategic internal and external communications/public relations programming to help optimize the growth of Shire’s marketed product portfolio and articulate the value of the Company’s pipeline portfolio. She also serves as a member of both the U.S. Commercial and the Communications & Public Affairs senior leadership teams.

Before joining Shire, Gwen worked at Pfizer, where she served as a company spokesperson in the global media relations department. In that position, one of her key accomplishments was repositioning the reputation of Pfizer’s business development efforts. Gwen joined Pfizer through its acquisition of Wyeth, where she served as Assistant Vice President, Global Public Relations, overseeing brand communications and issues management for the pharma business unit. While in that role, Gwen was instrumental in creating the award-winning “Depression is Real” campaign and coalition. She also served as a trusted counselor and advisor to the head of that business. Gwen began her pharmaceutical industry career at Merck & Co., Inc. She has also worked in other industries, including at Tyco, Transamerica Life Companies, ARCO (oil and gas), Childrens Hospital – Los Angeles, and Westinghouse Hanford Company.

Gwen holds a B.A. in Communications from the Edward R. Murrow College of Communication at Washington State University and an MBA from the Anderson School at the University of California, Los Angeles.


Deborah Fowler
Managing Partner, GREEN ROOM COMMUNICATIONS

view speaker profile

Deborah Nettune Fowler’s expertise in media stems from more than 10 years of experience in the field as an award-winning television reporter and news anchor in major markets across the country, as well as working in TV production. She produced newscasts and acted as a videographer, field producer, editor, writer and associate producer for ABC and FOX News affiliates in Long Island, NY; Burlington, VT; and Chattanooga, TN. Most recently, she served as a general assignment reporter and associate producer at KDFW, the FOX affiliate in Dallas, TX. Her PR experience started at DWJ Television, where she served as Media Director and headed up a team of eight Media Placement Specialists. In 2003, Deborah launched Original Media Concepts, a media relations firm specializing in media strategy and placement. In 2008, she brought her media prowess to Green Room Communications. As Green Room PR’s partner focused on media strategy, Deborah brings her expertise to the early stages of PR strategic planning to ensure that key messages are timely and relevant.

Deborah is also the President and Founder of Soft Bones: The U.S. Hypophosphatasia Foundation, a non-profit organization that raises awareness for the rare bone disease.

In addition to organizing the patient community around this orphan disease, she has conducted Congressional Briefings and lobbied on Capitol Hill to raise awareness of rare diseases, and currently works with the National Institutes of Health and the Social Security Administration to support research efforts and to ensure that patients are entitled to government benefits.

Deborah is currently an active member in Healthcare Businesswomen’s Association (HBA) and serves on the Regional Programming Board for the New York/New Jersey Region. She was awarded the HBA’s highest award for Leadership Excellence and Dedication in 2017.

She has been recognized as a Leading Woman Entrepreneur in New Jersey and, in 2014, she was among the top 25 in the state. In 2014, she was also recognized by the Boy Scouts of America as Woman of the Year. In 2016, she was awarded Brava’s SmartCEO award and the Women’s Venture Fund Highest Leaf Award.


Michele Gannon
President, MARY’S PLACE BY THE SEA

view speaker profile

Michele Gannon takes a vision and makes it reality by uniting the people around her. Her vision for Mary’s Place by the Sea began when recovering from an illness in January of 2009. Michele realized how trying it can be for women to maintain their own physical and emotional health when dealing with their daily responsibilities at home and work; she wondered how much more difficult it could be when diagnosed with a life-altering disease. Michele set out with her friend and co-founder, Maria McKeon, to establish a safe haven where women with all forms of cancer could go to receive integrative services during and after their medical treatment, at no cost. Less than six months later, Mary’s Place by the Sea welcomed its first guest.

Michele intuitively found supporters in her local community, who would commit to helping women with cancer, so that the guests of Mary’s Place could experience true healing of the mind, body and soul, with no financial burden. Harnessing the support of individual donors, corporate organizations, third-party fundraisers, and over 150 volunteers Michele has grown the organization from what started as two bedrooms rented in a bed and breakfast, to a custom-built, state-of-the-art, ten-bedroom home just a block from the Atlantic Ocean in Ocean Grove, New Jersey. Over 8,000 women with cancer from around the nation have visited this sanctuary by the sea.

Michele is an inspirational leader who tells stories that motivate and inspire, while remaining grounded in the very real experiences of the guests of Mary’s Place. Michele has a Master’s Degree in Education from West Virginia University and is a 2013 graduate of the Institute for Integrative Nutrition in New York. Michele draws on her broad experience in higher education and customer service to oversee all operations of the organization. Respected as a credible voice in non-profit operations, donor recruitment and retention, and relationship-building, Michele has been recognized as one of the Top 25 Women Entrepreneurs in New Jersey.

Michele’s vision is to grow Mary’s Place by the Sea into a nationwide organization, with other satellite homes around the country.Her dream is that every woman with cancer would have access to the healing atmosphere of Mary’s Place.


Denise Goodbar
Program Manager, SOFT BONES, INC.

view speaker profile

Denise Goodbar joined Soft Bones, The U.S. Hypophosphatasia Foundation in 2015 to support the growing patient community for this ultra-rare bone disease. In her current role as Program Manager for Soft Bones, she is responsible for managing the organization’s various programs, which includes managing patient issues, connecting them with resources for support, and liaising with partners in the rare disease community. As the mother of a son with severe allergies, she knows how patient and caregiver insights are powerful and can fuel programs that mutually benefit everyone involved.

Prior to joining Soft Bones, Denise worked at Andersen Consulting (now Accenture) with a focus on management consulting and at the Food Group and Four Seasons Hotel in the hospitality industry in advertising and operations. She has a BS in Hotel Administration from Cornell University and an MBA from the University of Colorado Boulder. She is the mother of four boys and currently lives in Mountain Lakes with her husband, Bill, and dog, Chloe.


Staci Gouveia
Senior Director, Commercial Communications, MALLINCKRODT PHARMACEUTICALS

view speaker profile

Staci Gouveia is a seasoned communications and public relations professional with 20+ years of experience supporting the healthcare industry (human and animal) and global communications for leading companies.

Currently, Staci is Senior Director of Commercial Communications at Mallinckrodt Pharmaceuticals, an innovation-driven specialty pharmaceutical growth company focused on improving outcomes for patients with severe and critical conditions. At Mallinckrodt, Staci is responsible for strategic internal, external, and executive communications for the Specialty Brands commercial business of Mallinckrodt based in Bedminster Township, New Jersey. In her role, Staci drives strategic communications plans and serves as corporate communications and public relations counselor for the Specialty Brands businesses. Staci is a patient-focused, innovative and adaptable leader who drives results, embraces creativity, enables effective change management and encourages transparency and collaboration at all organizational levels.

Prior to joining Mallinckrodt, Staci spent 11 years at the Bayer Corporation, most recently as the Communications Director of the U.S. Animal Health Division of Bayer HealthCare. In this role, Staci served as the communications leader and a member of the company’s U.S. Animal Health Executive Management Team reporting to the President and General Manager of North America and other company executives globally. She oversaw a range of communications and public relations functions, including internal, external and corporate communications in the U.S. and globally, integration with global counterparts and colleagues, and product and pipeline public relations strategic initiatives. In addition, Staci was Deputy Director, Global Communications for Bayer HealthCare Diabetes Care for three years.

Staci began her communications career at Ketchum, a top-ranked global communications agency with offices around the world, where she worked for six years.

Staci has participated in numerous employee and women’s leadership initiatives at Bayer and Mallinckrodt and is the recipient of more than 25 special recognition awards in leadership, service, teamwork, and excellence in communications. She served as a Board Member of Science Pioneers 2013-2014, is a member of the National Association of Professional Women, and a graduate of Women Unlimited, Inc., Leadership Education and Development (LEAD) program for high potential women.

Staci holds a Master of Arts in Communication Arts from New York Institute of Technology and a Bachelor of Arts Multidisciplinary Studies from Stony Brook University in New York.


Danielle Halstrom
Head, R&D and Commercial Communications, BRISTOL-MYERS SQUIBB


Toni Haubert
Senior Manager, U.S. Public Affairs, ABBVIE

view speaker profile

Toni has more than 12 years of healthcare communications experience with both industry and leading global PR agencies, developing multi-channel programs that educate stakeholders about important healthcare issues, diseases and treatments. She currently represents women’s health and specialty products and has worked on products across several therapeutic areas, including immunology, oncology, neurology and rare diseases.

Toni joined AbbVie in 2016 in her current role where she executes multiple U.S. external communications programs, including the award-winning “Get in the Know about ME in EndoMEtriosis” campaign featuring celebrity spokesperson Julianne Hough.

Prior to AbbVie, Toni worked at W2O Group, Weber Shandwick and Tonic Life Communications (formerly Dorland Global Public Relations), where she developed communications programs for clients, including AbbVie, Shire, Otsuka/Lundbeck, the Pulmonary Fibrosis Foundation, EMD Serono, Pfizer, Gilead and Genentech.

Toni attended Ohio University and graduated magna cum laude with a bachelor’s degree in journalism/public relations.


Laura Hortas
Head of Corporate Communications, BRISTOL-MYERS SQUIBB


Kelly Jansen
Director Corporate Communications and Content Strategy, HORIZON PHARMA

view speaker profile

Kelly Rothschild Jansen serves as director, corporate communications and content strategy at Horizon Pharma, plc. In this role, Kelly oversees corporate brand strategy, content creation and messaging across all internal and external platforms. Kelly has more than 15 years of experience in content development and execution, including expertise in corporate storytelling, large scale production, video, visual design and multimedia planning.

Prior to joining Horizon Pharma, Kelly served as co-executive producer for Harpo Studios where she oversaw the iconic Oprah Winfrey brand through ground floor content development and strategy. Kelly was responsible for execution of series media, including all creative, post production and brand management. Additionally, Kelly developed and implemented marketing, social media, digital, promotion and publicity rollouts surrounding various international campaigns.

Previously, Kelly was a news producer at WNDU-TV, an NBC affiliate, where she oversaw a daily newscast from concept to air, including managing a large team of reporters, editors, directors, technical operators and creative staff, as well as script writing, live feeds, editing and production logistics.

Prior to joining WNDU, Kelly was an Assistant News Producer for Fox28 News.

Kelly graduated cum laude from Indiana University with a Bachelor of Arts in Journalism from the Ernie Pyle School of Journalism. She also studied law at Loyola University Chicago School of Law. A Chicago transplant, Kelly now lives in Deerfield, Illinois with her husband and three children.


Omar Khateeb
Director of Growth Marketing and Branding, POTRERO MEDICAL

view speaker profile

Omar Khateeb is based in Silicon Valley and develops strategies based on behavioral economics and digital transformation to guide healthtech companies adapt to newly connected markets. He has developed marketing strategies at two publicly traded surgical robotic companies through their IPOs as well as co-founded and successfully launched a fashion inventions company.

He currently serves as Director of Growth Marketing and Branding at Potrero Medical, a predictive health company that is developing the next generation of smart sensors and artificial intelligence.

You can connect with Omar on LinkedIn, Facebook, Instagram, Twitter, or SnapChat as he shares industry knowledge and the latest marketing strategies out of Silicon Valley.


Moyra Knight
Executive Director, Communications and Corporate Citizenship, ASTELLAS US LLC

President, ASTELLAS USA FOUNDATION

view speaker profile

Moyra Knight is Executive Director of Communications and Corporate Citizenship at Astellas in the Americas region and is President of the Astellas USA Foundation. She is responsible for developing and leading corporate brand initiatives and reputation management to achieve Astellas’ strategic business goals across North and South America. She also oversees executive communications, employee and digital communication, issues management, product communications, media relations and corporate social responsibility. A member of the Astellas Corporate Affairs Leadership Team, Knight reports directly to Senior Vice President of Corporate Affairs Jeffrey A. Winton. Knight has more than 25 years of communications experience in both the health care and consumer industries including Baxter International Inc., Ogilvy Public Relations Worldwide and Kraft Foods, Inc.


Seema Kumar
Vice President, Innovation, Global Health and Science Policy Communication, JOHNSON & JOHNSON

view speaker profile

Seema is Vice President of Innovation, Global Health and Science Policy Communication for Johnson & Johnson. In this role, she drives Johnson & Johnson’s reputation as a pioneer and partner of choice in innovation, research and development (R&D), and public health. Her responsibilities include enterprise-wide communications regarding Johnson & Johnson innovation and R&D in pharmaceuticals, medical devices and consumer products, as well as medical safety and ethics, domestic and international policy affecting the sciences, and public health. She leads communication for the Office of the Chief Scientific Officer, including the Johnson & Johnson Innovation Centers and the Office of the Chief Medical Officer. As a champion of science and innovation, STEM, global health, and mentorship for women and minorities, she is a frequent guest speaker and lecturer at international forums.

Previously, Seema served as the Vice President, Enterprise Innovation and Global Health Communication, J&J, and as Vice President, Global R&D Communication for Janssen, the Pharmaceutical Companies of J&J, which included oversight of internal and external communications. As part of the Pharmaceutical R&D management team, she led important initiatives to position Janssen, and J&J, as a pharmaceutical R&D leader and oversaw J&J-level R&D communication programs managing the reputation of the J&J pharmaceutical pipeline and products, and the Company’s leadership in global health. Seema joined the J&J Family of Companies in 2003 as Vice President, Global Communications for J&J Pharmaceutical Research & Development, serving in that position until 2009. During this time, she built a new J&J Global R&D Communications function and organization, setting and achieving ambitious goals to showcase J&J ‘s cutting-edge scientific research and innovative drug-development processes.

Prior to joining J&J, Seema was the Chief Communications Officer at the Whitehead Institute for Biomedical Research /Massachusetts Institute of Technology (MIT) Center for Genome Research, the flagship center for the Human Genome Project. She played a leadership role in enhancing worldwide public awareness and understanding of Project, the effort to map and sequence the genetic blueprint for a human being. As a member of the Center’s executive management, Seema was at the White House along with the Project team for the first global announcement of the Human Genome sequence. Seema also held positions of increasing leadership at the Whitehead Institute, the National Institutes of Health and the Johns Hopkins

Medical Institutions, where she launched and led a variety of initiatives to communicate and position the latest scientific advances and policy implications and STEM initiatives for high school students.

A passionate champion of science, Seema is active in many professional affiliations and serves on several external advisory boards. She serves on the ESOF2016 Science to Business Committee, served on the ESOF14 Marketing and Media Committee and oversaw J&J’s role in becoming a founder and continued sponsor of ESOF. She is the author of more than 200 news and feature articles on science and medicine, for which she has won several awards, including an Award of Excellence in writing from the American Medical Writers Association and three Gold Medals for Media Relations, Science Education, and Digital Communication. She holds a master of arts degree in science journalism from the University of Maryland, which included a fellowship at the National Cancer Institute, and a bachelor of science and communication from the University of Maryland, and a bachelor of science in physics from Stella Maris College, in Madras, India.

Growing up in India, Seema was taught from an early age by her father, a physicist and an engineer, the importance of a STEM education to advance societal innovation and from her mother she learned the art of storytelling. Today, Seema lives in New Jersey with her husband and teenage son. In her free time, she enjoys healthy cooking, reading and spending time with friends and family.


Joe Lazauskas
Head of Content Strategy, CONTENTLY

Co-Author, THE STORYTELLING EDGE: HOW TO TRANSFORM YOUR BUSINESS, STOP SCREAMING INTO THE VOID, AND MAKE PEOPLE LOVE YOU

view speaker profile

Joe is the head of content strategy at Contently and the co-author of a best-selling book, The Storytelling Edge: How to Transform Your Business, Stop Screaming Into the Void, and Make People Love You. He’s also the Executive Editor of The Content Strategist, winner of the Digiday Award for Best Brand Publication. A technology and marketing journalist, Joe is a regular contributor to Fast Company and has written for Mashable, Digiday, and Forbes, and many other publications.


Michael Losow
Director, Patient and Professional Advocacy, AMICUS THERAPEUTICS

view speaker profile

Michael Losow is the Director of Patient and Professional Advocacy at Amicus Therapeutics.  Michael started his career in public policy advocating for people living with multiple sclerosis, rare diseases, and disabilities.  He later became the lead liaison building alliances with the patient and healthcare professional organizations and individuals for the biopharmaceutical trade association, BIO.  He has since worked for Talecris Biotherapeutics, Onyx Pharmaceuticals and Amicus as a leader in patient advocacy as well as federal and state public policy


Wendy Lund
CEO, GCI HEALTH

view speaker profile

Wendy joined GCI Health as Chief Executive Officer in 2010 and is responsible for setting and carrying out a vision for the agency. Seven years later, GCI Health was recently named North American Healthcare Agency of the Year for the 3rd time, Global Healthcare Agency of the Year for the 2nd time and also won the distinction of being awarded Best of Best Place to Work in May 2017 from The Holmes Report. Wendy has dedicated her entire career to healthcare communications and marketing. With almost 30 years of healthcare communications and marketing experience, she puts patients at the center of everything she does.

She has worked with a diverse group of pharmaceutical, biotech, medical technology companies globally and in the U.S.; on a corporate level and across a variety of disease categories from the most serious and rare diseases to those affecting millions of consumers (like heart disease, cancer and diabetes). She thrives on partnering with clients to solve the most difficult communications challenges they face.

Wendy spent the first 13 years of her career in the non-profit industry as VP of marketing at Planned Parenthood Federation and VP of marketing at the National League for Nursing and has worked with a variety of health network and programs targeting professionals. Wendy was named one of MM&M/PRWeek’s top 50 Health Influencers in 2016 and 2017, PRWeek’s True Women Champions of PR, was inducted into the 2016 and 2017 PR News Class of Top Women in PR and was named a finalist for the 2016 PRWeek’s Agency Professional of the Year.

Wendy has a Master’s degree in history from New York University and studied abroad in London.


Markeisha Marshall
Senior Manager, Public Affairs, ABBVIE

view speaker profile

Markeisha Marshall has spent nearly 15 years working with powerhouse brands, corporations and executive officers to craft traditional and digital communication strategies to launch products, reinforce ideals and drive target audience engagement.

In 2016, Markeisha joined AbbVie as a senior manager in Public Affairs. In this role Markeisha has led launch communication strategies across oncology and virology therapeutic areas. Also, she has received an award for the development and execution of communication strategy in support of those living with cystic fibrosis.

Prior to joining AbbVie, Markeisha served as senior strategic communication manager and media relations manager, respectively, at Walgreens Co. In those roles, Markeisha was a core member of corporate executives’ leadership teams and led external communication strategy for health and wellness initiatives and divisions, including Walgreens Specialty Pharmacy. As a part of her work in specialty therapeutic areas, Markeisha received an industry award for the development and execution of Well Beyond HIV, an awareness campaign celebrating those aging with HIV. Additionally, Markeisha received recognition for her work in support of the implementation of the Affordable Care Act at a May 2014 White House reception.

Before joining Walgreens, Markeisha served as an account director at Weber Shandwick in Detroit, Chicago and Singapore working across Fortune 500 companies’ consumer lifestyle, dermatological and technology brands. Prior to joining Weber Shandwick, Markeisha served as a marketing communications manager for Aetna’s global division.

Markeisha began her career at FleishmanHillard as a member of the consumer marketing team and garnered invaluable experience co-designing health and wellness initiatives for leading consumer health brands including Nike and Gatorade.

Markeisha’s approach reflect her experience in consumer health, global commercial health insurance, corporate retail and specialty pharmacy and biopharmaceutical communication strategy, as well as her master-level education in health intervention design from Northwestern University.


Kendra Martello
Senior Director, Public Policy, Government Affairs and Public Policy, MALLINCKRODT PHARMACEUTICALS

view speaker profile

Kendra is an experienced attorney, advocate, and government affairs professional skilled in strategic counseling, advocacy, legal and policy analysis, and government and regulatory affairs at top-tier multi-national law firms and industry-leading trade associations.

She is a successful advocate with experience in Congressional and state testimony and in engaging elected and appointed officials and professional staff in federal and state legislative bodies and executive agencies. She has presented at a multitude of conferences and events, regularly prepares briefings and materials for C-level executives, has worked extensively with third-party stakeholders, and has served regularly as a media spokesperson.

In her current role, she is responsible for state and federal policy on behalf of Mallinckrodt Pharmaceuticals, a multibillion-dollar specialty pharmaceutical company focused on the mission of Managing Complexity. Improving Lives. Mallinckrodt provides medicines to address unmet patient needs, particularly in the autoimmune and rare disease area, with a rich 150-year history in developing and marketing products to improve patient’s lives.

Kendra received her JD from American University’s Washington College of Law and her BA in Political Science from the University of Maryland. She also serves as the Chair of the Commission for Women in Alexandria, Virginia, which advises the Mayor and City Council on issues of importance to women and girls in the City.


Lauren McCurdy
Lead Medical Producer, MULTIVU

view speaker profile

Lauren McCurdy is the lead medical producer for MultiVu, specializing in healthcare and pharmaceutical video production.  She has been with the company for several years, having previously worked for CNN’s Anderson Cooper.   During her time at MultiVu, her experience and expertise has spoken to FDA approvals, patient testimonials, medical device videos, and new advances in medical therapies and technologies. Her utmost priority is meeting client needs in regards to the regulations mandated by the FDA.  She is passionate in learning new advances in medicine and working with the MultiVu team to break the news of new therapies to the affected patient population in a targeted effort.


Amanda Mitchell
Founder, OUR CORPORATE LIFE LLC

view speaker profile

In her role as Corporate Navigator, Amanda works with senior executives and their teams to mitigate the business impact of disruptive drama. She and her team provide one-on-one executive coaching, conduct conflict interventions, and facilitate change management initiatives.

As a former advertising executive responsible for the overall management and profitability of several Manhattan agencies, she has experienced first-hand the challenges executives face.

She has written for Bloomberg Businessweek and been quoted in Fast Company, US News and World Report, CNBC.com, and other national media outlets and is an established thought leader on Twitter https://twitter.com/OurCorpLife

She holds the Professional Certified Coach (PCC) credential through the International Coach Federation and is certified in Conventional Intelligence, a framework that helps leaders create effective, powerful conversations to improve business results.

She has a BA from Michigan State University and lives in New Jersey with her family.


Agatha Newman
Associate Director, Medical and Development Communications, ASTELLAS

view speaker profile

Agatha is passionate storyteller able to digest complex information into actionable strategies to accelerate new growth and innovation. Curious, collaborative and a constant learner, Agatha has more than 15 years of experience driving change management and leading strategic communications to help companies meet their vision through employee engagement programs, therapeutic and brand support, patient engagement programs and strategic partnerships.

Agatha is a believer in integrated, channel-agnostic solutions that engage audiences, create conversations and build communities.

Agatha currently works at Astellas, a global, research-based biopharmaceutical company, within Medical & Development Communications leading executive leadership communication and employee engagement.

Prior to Astellas, Agatha worked at AbbVie in various positions, including Global and Corporate Communications where she was responsible for overseeing the international strategies for pre-launch and on-market therapies in immunology, virology and neuroscience.

Agatha’s experience spans a variety of industries, from pharmaceuticals, healthcare and technology to consumer packaged goods, retail, manufacturing and financial services. She has worked with Fortune 500 companies including P&G, Hanesbrands, Kraft Foods, CKE Restaurants, ExxonMobil, Newell Brands, MillerCoors and MasterCard in a variety of capacities, including event/celebrity sponsorship, issues/crisis management, media relations, influencer engagement and executive communication. She’s served leadership roles in agencies including Weber Shandwick and O’Malley Hansen and also worked at Anheuser Busch on the innovation and trademark team.

Agatha graduated magna cum laude from St. Louis University with a double major in communication and marketing from the Olin School of Business. A native St. Louisan, Agatha currently lives in Chicago with her husband, two sons and four-legged daughter Liberty (a sweet golden retriever).


Sonali Patel
Lead Graphic Designer, MULTIVU


Rebecca Perkins
Vice President of Government Affairs, BIO NJ


Elizabeth Presson
Patient Engagement and Digital Strategy Lead, OTICON MEDICAL

view speaker profile

Liz Presson works at the intersection of patient engagement, innovation, and digital strategy with pharmaceutical and medical device companies. She’s led innovation initiatives for Fortune 500 Pharma organizations, built advocacy programs for medical device companies that doubled the bottom line, and has helped transform influential healthcare organizations into digital leaders. Liz takes the stage at conferences like Stanford’s Medicine X, Technori, World Maker Faire, Internet Summit, and others. She contributes articles on company culture, entrepreneurship, and technology to publications like Fast Company, Forbes, Inc., and Mashable.


Allen Reha
Vice President, Program Management, AMICUS THERAPEUTICS

view speaker profile

Allen Reha currently serves as Vice President – Head of R&D Program Management at Amicus Therapeutics and operated in the role of Program Leader for the SD-101 program in epidermolysis bullosa. Mr. Reha previously served as Vice President and Head of Program Management and Clinical Operations at PTC Therapeutics. At PTC, Mr. Reha served in a leadership capacity in the clinical development, regulatory approval, commercialization of Translarna™ (ataluren) for Duchenne muscular dystrophy (DMD). Prior to working at PTC, Mr. Reha was with Novartis, where he served in various roles of clinical research and data management. While at Novartis, he was involved in the clinical development and commercialization of Gleevec® (a treatment for chronic myelogenous leukemia and other diseases) as well as the clinical development of compounds for other orphan diseases including acromegaly, Cushing’s disease, and gastroenteropancreatic neuroendocrine tumors.   Prior to Novartis, Mr. Reha worked in clinical development at Hoffmann-La Roche. Collectively, Mr. Reha brings ~20 years of industry experience in drug development and commercialization, focusing in orphan disease and pediatric indications. Mr. Reha received a B.A. in Biological Sciences from Rutgers College and a M.S. in Management Science from the Wesley J. Howe School of Business, Stevens Institute of Technology


Tierney Saccavino
Executive Vice President, Corporate Communications, ACORDA THERAPEUTICS

view speaker profile

Tierney Saccavino has been the Executive Vice President of Corporate Communications at Acorda Therapeutics since January 2015. She is responsible for the company’s corporate communications, media relations, corporate website and social media programs, as well as its philanthropic giving, community outreach and consumer/advocacy relations. She has held various roles of increasing seniority in the Corporate Communications department since 1998.

Before joining Acorda, Ms. Saccavino had more than 15 years of experience in public relations, marketing and corporate communications. She was the Manager of Corporate Relations at Adventis, a Boston-based management consulting firm focusing on the media, communications and telecom industries. In that capacity, she was responsible for public relations, corporate promotions and executive education programs. She also worked for nine years in a variety of positions at Fidelity Investments. Ms. Saccavino attended the University of Connecticut in Storrs, Connecticut.


Sarah Spencer
Head, U.S. Corporate Communications, GLAXOSMITHKLINE (GSK)

view speaker profile

Sarah J. Spencer is a seasoned communications professional with more than 20 years of experience in healthcare and life sciences communications. Ms. Spencer is currently Head, US Corporate Communications at GlaxoSmithKline (GSK) where she leads media relations, crisis communications, reputation management and business strategy & financial communications for the US market. Ms. Spencer spent nine years of her career at GSK working in the Company’s corporate headquarters in London in product and pipeline public relations as well as leading corporate & financial and consumer healthcare media relations for the Group.

Prior to GSK, Ms. Spencer worked in both boutique healthcare agency and small biotech settings, where she honed her skills in creative campaign development, persuasive writing and decisive media handling. Ms. Spencer began her career at Rite Aid Corporation where one of her first assignments was representing the Company’s new store development plans at community planning meetings in small towns in New England. She also handled hundreds of crisis events throughout cities across the U.S. where the company operated its stores and a corporate accounting scandal resulting in criminal indictments of top company officials.

Ms. Spencer holds a B.S. in Communications & Psychology from the State University of New York (SUNY) at Buffalo.


Mary Kathryn Steel
Corporate Communications, ABBVIE

view speaker profile

Mary Kathryn Steel recently joined AbbVie as Director of Corporate Communications, a role in which she focuses on government affairs, access, corporate responsibility and litigation. Prior to AbbVie, she was the head of US Media Relations and Branding at Sanofi, where she led a team responsible for media, digital, reputation and branding. She managed the response to a number of crises involving pricing, recalls, patents and product liability.

Mary Kathryn joined Sanofi from FTI Consulting, a global business advisory firm, where she ran the Washington-based healthcare practice, and her clients included the GE Foundation, the Novo Nordisk Foundation, Pfizer and Shire. Mary Kathryn began her career at The Coca-Cola Company in Public Affairs in Issues Management. A New York Times-published essayist, Mary Kathryn chairs the Coca-Cola Scholars Foundation’s advisory board, a nonprofit that has awarded $50 million in college scholarships to 5,000 American high school students.


Mark Trudeau
President and CEO, MALLINCKRODT PHARMACEUTICALS

view speaker profile

Mark Trudeau is the President and Chief Executive Officer of Mallinckrodt Pharmaceuticals.

Mr. Trudeau was formerly Senior Vice President of Covidien’s pharmaceuticals business, with experience in markets around the world. Originally from Detroit, Michigan, he has lived and worked in Singapore, Canada, and the United Kingdom, as well as in the United States.

Prior to his tenure at Covidien, Mr. Trudeau served as President and CEO of Bayer HealthCare Pharmaceuticals. He simultaneously served as interim president of the global specialty medicine business unit from January to August 2010.

Before joining Bayer in 2009, Mr. Trudeau headed the Immunoscience division at Bristol-Myers Squibb. During his more than 10 years there, he served in multiple senior roles, including as President of the Asia/Pacific region, President and General Manager of Canada operations, and General Manager/Managing Director of UK operations. Mr. Trudeau was also previously with Abbott Laboratories, serving in a variety of executive positions. He began his career in engineering at Eli Lilly and Company and at E.I. DuPont De Nemours and Company.

Mr. Trudeau holds a Bachelor’s degree in chemical engineering and a Master’s of Business Administration, both from the University of Michigan.


Mark Tyndall
Vice President, Government Affairs, Public Policy and Advocacy, MALLINCKRODT PHARMACEUTICALS

view speaker profile

MARK TYNDALL serves as Vice President of Global Government Affairs, Policy and Patient Advocacy for Mallinckrodt Pharmaceuticals, where he has global responsibility for the company’s engagement with governments, trade associations and other external stakeholders, as well as the company’s corporate social responsibility and charitable contribution programs.

In this role, Mark serves as the primary political and policy advisor to Mallinckrodt’s Chief Executive Officer and Executive Committee and regularly presents to the Board of Directors on matters relating to the political and policy environment. As a member of the corporate communications leadership team, Mark plays a key role in issues management and investor communications. He also serves as a standing advisor to the corporate pricing and enterprise risk management committees.

Prior to Mallinckrodt, Mark served as Head of Global Policy and Public Affairs at Bayer Healthcare’s Consumer Care division, where he established the global policy function, oversaw the division’s worldwide trade association activities, and served as the primary policy advisor to the global president and senior management team.

Prior to joining Bayer, Mark practiced healthcare law in the Washington, D.C. office of Sidley Austin LLP, where he focused on healthcare legislative and policy matters, healthcare fraud and abuse issues, and global healthcare policy issues. He is also a former Professional Staff Member at the U.S. Senate Committee on Agriculture, Nutrition and Forestry.

Mark holds a Juris Doctor from George Washington University Law School, a Master’s degree in Public Policy from the College of William and Mary, and a Bachelor of Arts degree in Economics, cum laude, from Christopher Newport University. Mark resides in Washington, D.C.


Gloria Vanderham
Global Head, Social and Digital Media, NOVARTIS ONCOLOGY


Patrick J. Witmer
Director, Global Communications, MERCK

view speaker profile

Patrick Witmer is a public affairs and communications leader with a broad range of experience addressing stakeholder issues across industry, government and higher education.

Pat joined Merck in 2002, and currently serves as director of global communications where he leads external communications on market access, affordability, and collaborations with the company’s top customers in the U.S. Pat previously led global communications for Merck’s cardiovascular and immunology franchises, and internal and external communications for the U.S. Market organization. He also directed public affairs teams in Merck’s Global Public Policy & Corporate Responsibility organization and the Merck Manufacturing Division. Pat has led high profile projects in areas including patient engagement, corporate responsibility, crisis communications and transparency, including publishing the pharma industry’s first pricing transparency report and Merck’s first physician payment transparency report.

Since 2014, Pat has been an adjunct faculty member in the MBA program at DeSales University, teaching on topics including business ethics, stakeholder engagement, public policy, reputation management, and corporate responsibility.

In previous roles, Pat led federal, state and local government relations for Air Products and Chemicals, Inc., was regional sales administrator of a four-state territory for 3M, was director of government affairs for the New Jersey State Chamber of Commerce, and served as legislative director and legislative assistant to two members of Congress during his four years on Capitol Hill.

Pat has served in a variety of leadership positions for national and state industry organizations, and presented at national and state-wide conferences on topics ranging from corporate transparency to free trade. In the community, he serves on the Alumni Leadership Council of the Fels Institute of Government at the University of Pennsylvania, the Board of Directors of the Forum for Ethics in the Workplace at DeSales University, and the Advancement Committee of the Pennsylvania Shakespeare Festival.

Pat received a Master of Public Administration degree from the Fels Institute of Government at the University of Pennsylvania. He was the 2009 Executive Program recipient of the Fels Institute of Government Academic Achievement Award. He also holds a BA in Economics and Political Science from Millersville University.


Paul Wynn
Oncology and Rare Disease Public Relations and Patient Advocacy Rotation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

view speaker profile

Paul Wynn leads communications strategy for several specialty care teams at Boehringer Ingelheim. He oversees both external and internal communications and all social media efforts for several in-market brands and multiple pipeline products for oncology and rare diseases. During his four years at BI, Paul has led the department’s comprehensive measurement efforts, contributed to a cross-functional team to renew the company’s patient-centric approach and was selected to participate in a management development program. In social media, Paul has led several firsts at the company, including first live therapeutic Twitter Chat, first Facebook Live Event streamed simultaneously over Global and US social media channels and first takeover of BI channels by patient advocacy groups.

In 2018, Bulldog Reporter recognized BI’s Breathless campaign with a Silver Award for the Best Use of a Celebrity. Yankee legend and Latin-Grammy nominated musician Bernie Williams serves as the celebrity spokesperson for the Breathless campaign to raise awareness of idiopathic pulmonary fibrosis, a rare lung disease that took his dad’s life in 2001.

Paul is currently serving a rotation with BI’s Patient Advocacy and Professional Relations (PAR) team, managing relationships with scleroderma patient advocacy groups. He will oversee planning for the Scleroderma Foundation Patient Education Conference and coordinate the company’s sponsorships and presence at the annual meeting.

An accomplished writer, Paul was formerly senior editor with Med Ad News and Managed Care magazines. He has contributed to more than 55 publications like Health, Prevention, Medical Economics, MM&M and Drug Topics. He is a regular contributor and columnist to Diabetes Self-Management, New Physician and Pain-Free Living.

Prior to joining BI, Paul consulted with Purdue Pharma and held senior positions at several public relations agencies in New York City. Paul received a Bachelor of Science from the Roy H. Park School of Communications at Ithaca College.